Status:
COMPLETED
Double-bed SPECT/CT for Bone Scintigraphy in Initial Staging of Cancer Patients
Lead Sponsor:
University Hospital, Brest
Conditions:
Bone Metastases
Eligibility:
All Genders
18+ years
Brief Summary
Bone scintigraphy is currently a reference test in the initial staging of cancer. Bone scintigraphy historically consists in a planar whole-body scintigraphy (WBS). SPECT/CT has been shown to dramatic...
Detailed Description
Images are interpreted by two nuclear medicine physicians in a 3-step procedure and by consensus. Firstly,only WBS planar images are considered. Secondly, a single-bed SPECT/CT chosen based on planar ...
Eligibility Criteria
Inclusion
- Patients referred for bone scintigraphy for initial staging of biopsy proven malignancy.
Exclusion
- monoclonal gammapathy
- patients under 18 years of age
- Technical issues not allowing a double-bed SPECT/CT acquisition
- double bed SPECT/CT acquisition not centered from the upper cervical spine to the proximal femora
Key Trial Info
Start Date :
October 10 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 10 2016
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT03353090
Start Date
October 10 2016
End Date
December 10 2016
Last Update
November 27 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU de Brest
Brest, France, 29609